NCAM1 and ischemic cardiomyopathy: also demonstrated that up‐regulation of the 140‐kD isoform of CD56 (NCAM1) might play an important role in the pathogenesis of ischemic cardiomyopathy and could serve as a target in the treatment of this disease (Tur et al., 2013).